hydroxychloroquine has been researched along with Inflammatory Response Syndrome, Systemic in 4 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Three patients had concurrent positive coronavirus disease 2019 (COVID-19) infection, and the other 2 patients had contact with suspected COVID-19 positive patients." | 1.62 | Multi-system inflammatory syndrome in children during the coronavirus disease 2019 in Saudi Arabia: Clinical perspective from a case series. ( Al-Qahtani, SM; AlHelali, I; Ali, AS; Asseri, AA; Awadalla, NJ; Elbastawisi, E; Shati, AA, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 4 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jacquet-Lagrèze, M | 1 |
| Riad, Z | 1 |
| Hugon-Vallet, E | 1 |
| Ferraris, A | 1 |
| Fellahi, JL | 1 |
| Mamishi, S | 1 |
| Navaeian, A | 1 |
| Shabanian, R | 1 |
| Kim, MG | 1 |
| Stein, AA | 1 |
| Overby, P | 1 |
| Kleinman, G | 1 |
| Nuoman, R | 1 |
| Gulko, E | 1 |
| Al-Mufti, F | 1 |
| Pisapia, JM | 1 |
| Muh, CR | 1 |
| Asseri, AA | 1 |
| AlHelali, I | 1 |
| Elbastawisi, E | 1 |
| Ali, AS | 1 |
| Al-Qahtani, SM | 1 |
| Shati, AA | 1 |
| Awadalla, NJ | 1 |
1 review available for hydroxychloroquine and Inflammatory Response Syndrome, Systemic
| Article | Year |
|---|---|
Left ventricular dysfunction in COVID-19: A diagnostic issue.
Topics: Azithromycin; Betacoronavirus; Biomarkers; Coronavirus Infections; COVID-19; Cytokine Release Syndro | 2020 |
3 other studies available for hydroxychloroquine and Inflammatory Response Syndrome, Systemic
| Article | Year |
|---|---|
Acute aortic dissection in a patient with Williams syndrome infected by COVID-19.
Topics: Adolescent; Anti-Bacterial Agents; Antiviral Agents; Aortic Aneurysm; Aortic Dissection; Aortic Sten | 2021 |
Fatal Cerebral Edema in a Child With COVID-19.
Topics: Anti-Bacterial Agents; Anticonvulsants; Brain Edema; Child; COVID-19; COVID-19 Drug Treatment; Diagn | 2021 |
Multi-system inflammatory syndrome in children during the coronavirus disease 2019 in Saudi Arabia: Clinical perspective from a case series.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Child; Child, Preschool; COVID-19; COVID-19 Drug | 2021 |